Ordinary Adjustment | Solactive US CNS Therapeutics Index | Effective Date 8th May 2025
Solactive US CNS Therapeutics Index:
In the ordinary adjustment, the following composition will be implemented effective open 8th May 2025:
ACADIA PHARMACEUTICALS INC |
ALKERMES PLC |
AVADEL PHARMACEUTICALS PLC |
AXSOME THERAPEUTICS INC |
Annexon Inc |
BIOGEN INC |
DENALI THERAPEUTICS INC |
ELI LILLY & CO |
HARMONY BIOSCIENCES HOLDINGS INC |
JAZZ PHARMACEUTICALS PLC |
MIND MEDICINE MINDMED INC |
NEUMORA THERAPEUTICS ORD |
NEUROCRINE BIOSCIENCES INC |
NEW BIOHAVEN |
PROTHENA CORP PLC |
SUPERNUS PHARMACEUTICALS INC |
VERTEX PHARMACEUTICALS INC |
XENON PHARMACEUTICALS INC |